与西方国家类似,亚太地区澳大利亚的花生过敏症患病率最高,约有 3% 的儿童受到影响。
Featured media on Novotech’s leadership and impact.
Expert insights and real-world perspectives.
In-depth perspectives on forces shaping clinical research.
Tracking science and trends across therapeutic areas.
Hear from experts shaping clinical development.
Conversations with leaders shaping drug development.
A global CRO and scientific partner advancing drug development.
Our impact extends beyond trials, shaping healthier futures worldwide.
A collaborative, science-driven approach.
Recognized for excellence across the industry.
Decades of clinical and scientific leadership.
A global clinical research leader with an award-winning culture.
A culture that empowers growth, innovation, and impact.
Explore career opportunities at Novotech.
Benefits and recognition that support your success.
Experts collaborating to advance clinical research.
A commitment to your growth and development.
Start your career in clinical research with Novotech.
与西方国家类似,亚太地区澳大利亚的花生过敏症患病率最高,约有 3% 的儿童受到影响。